<p>根据其最近向美国证券交易委员会（SEC）披露的信息，Baillie Gifford &amp; Co.在第三季度购买了 Heartflow, Inc.（NASDAQ:HTFL - 免费报告）的新头寸。该公司购买了 3,005,998 股该公司的股票，价值约为 101,182,000 美元。截至其最近向 SEC 提交的文件，Baillie Gifford &amp; Co.持有 Heartflow 3.60% 的股份。</p>
<p>其他几家对冲基金也买卖了 HTFL 的股票。Emerald Mutual Fund Advisers Trust 在第三季度购买了价值约 4,418,000 美元的 Heartflow 新头寸。TrueMark Investments LLC 在第三季度购买了价值约 918,000 美元的 Heartflow 新头寸。最后，TFC Financial Management Inc.在第三季度购买了价值约 40,000 美元的 Heartflow 新股份。</p>
<h2>华尔街分析师观点</h2>
<p>一些股票分析师对该股票发表了看法。Stifel Nicolaus 将 Heartflow 的目标股价从 35.00 美元上调至 40.00 美元，并在 11 月 13 日的研究报告中给予该股票 “买入” 评级。Canaccord Genuity Group 将 Heartflow 的目标股价从 39.00 美元上调至 40.00 美元，并在 11 月 13 日的研究报告中给予该公司 “买入” 评级。Weiss Ratings 在 12 月 29 日的研究报告中重申了对 Heartflow 的 “卖出（d）” 评级。最后，摩根大通将 Heartflow 的目标股价从 36.00 美元上调至 40.00 美元，并在 11 月 13 日的报告中给予该公司 “增持” 评级。四位投资分析师对该股票给予了买入评级，两位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，该股票的平均评级为 “持有”，共识目标价为 38.60 美元。</p>
<p><strong>查看我们关于 HTFL 的最新研究报告</strong></p>
<h2>Heartflow 股价下跌 4.0%</h2>
<p>NASDAQ:HTFL 的股票在周五以 32.16 美元开盘。该公司的市值为 27.4 亿美元，市盈率为-17.77。该股票的 50 日移动平均线为 30.42 美元。Heartflow, Inc.的 52 周低点为 25.38 美元，52 周高点为 41.22 美元。</p>
<h2>Heartflow 内部活动</h2>
<p>在其他新闻中，董事 Jeffrey C. Lightcap 于 12 月 16 日以每股 26.34 美元的平均价格购买了 40,000 股该公司的股票，总交易额为 1,053,600.00 美元。交易完成后，该董事直接持有该公司 40,000 股，价值约为 1,053,600 美元。这笔交易代表了其持股的∞增长。该收购在向证券交易委员会的文件中披露，相关信息可通过 SEC 网站获取。</p>
<h2>Heartflow 公司简介</h2>
<p>（免费报告）</p>
<p>HeartFlow, Inc. NASDAQ: HTFL 是一家医疗技术公司，开发用于冠状动脉疾病的非侵入性诊断解决方案。该公司的核心产品将冠状动脉 CT 血管造影（CTA）数据转化为患者特定的三维生理模型。通过先进的图像处理和计算建模，HeartFlow 的分析估算冠状动脉树中的分数流量储备（FFR）值，以识别导致缺血的病变，而无需进行侵入性的压力导丝测量。</p>
<p>HeartFlow 的基于云的服务与临床工作流程集成：临床医生提交冠状动脉 CTA 图像，并收到详细的彩色三维地图和报告，突出显示特定病变的 FFR 值和生理影响。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票比 Heartflow 更好</li>
<li>家族信托如何帮助保护您的财富</li>
<li>请勿删除，立即阅读</li>
<li>没有人告诉你的 100 万亿 AI 故事</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>用这四个简单步骤 “防止” 您的银行账户受到影响</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SFRGTA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SFRGTA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资 1,000 美元在 Heartflow 吗？</h2>
<p>在您考虑 Heartflow 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买...而 Heartflow 并不在名单上。</p>
<p>虽然 Heartflow 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HTFL

<p>Baillie Gifford & Co. 在 Heartflow, Inc. (NASDAQ:HTFL) 中获得了一个新头寸，在第三季度购买了 3,005,998 股，价值约为 1.0118 亿美元。这项投资代表了该公司 3.60% 的股权。其他对冲基金也投资了 Heartflow。分析师对该股票的评级不一，普遍目标价为 38.60 美元。Heartflow 的股票开盘价为 32.16 美元，市值为 27.4 亿美元。该公司专注于冠状动脉疾病的非侵入性诊断解决方案</p>

<p>Baillie Gifford &amp; Co. bought a new position in Heartflow, Inc. (NASDAQ:HTFL - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 3,005,998 shares of the company's stock, valued at approximately $101,182,000. Baillie Gifford &amp; Co. owned 3.60% of Heartflow as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>根据其最近向美国证券交易委员会（SEC）披露的信息，Baillie Gifford &amp; Co.在第三季度购买了 Heartflow, Inc.（NASDAQ:HTFL - 免费报告）的新头寸。该公司购买了 3,005,998 股该公司的股票，价值约为 101,182,000 美元。截至其最近向 SEC 提交的文件，Baillie Gifford &amp; Co.持有 Heartflow 3.60% 的股份。</p>
</div><p>Several other hedge funds have also bought and sold shares of HTFL. Emerald Mutual Fund Advisers Trust bought a new position in shares of Heartflow in the third quarter worth about $4,418,000. TrueMark Investments LLC bought a new position in shares of Heartflow during the 3rd quarter valued at approximately $918,000. Finally, TFC Financial Management Inc. purchased a new stake in Heartflow in the 3rd quarter worth approximately $40,000.</p>
<div class="lb-trans"><p>其他几家对冲基金也买卖了 HTFL 的股票。Emerald Mutual Fund Advisers Trust 在第三季度购买了价值约 4,418,000 美元的 Heartflow 新头寸。TrueMark Investments LLC 在第三季度购买了价值约 918,000 美元的 Heartflow 新头寸。最后，TFC Financial Management Inc.在第三季度购买了价值约 40,000 美元的 Heartflow 新股份。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>A number of equities analysts have weighed in on the stock. Stifel Nicolaus upped their price target on shares of Heartflow from $35.00 to $40.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, November 13th. Canaccord Genuity Group lifted their target price on shares of Heartflow from $39.00 to $40.00 and gave the company a &#34;buy&#34; rating in a research note on Thursday, November 13th. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Heartflow in a research note on Monday, December 29th. Finally, JPMorgan Chase &amp; Co. raised their price target on Heartflow from $36.00 to $40.00 and gave the company an &#34;overweight&#34; rating in a report on Thursday, November 13th. Four investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of &#34;Hold&#34; and a consensus price target of $38.60.</p>
<div class="lb-trans"><p>一些股票分析师对该股票发表了看法。Stifel Nicolaus 将 Heartflow 的目标股价从 35.00 美元上调至 40.00 美元，并在 11 月 13 日的研究报告中给予该股票 “买入” 评级。Canaccord Genuity Group 将 Heartflow 的目标股价从 39.00 美元上调至 40.00 美元，并在 11 月 13 日的研究报告中给予该公司 “买入” 评级。Weiss Ratings 在 12 月 29 日的研究报告中重申了对 Heartflow 的 “卖出（d）” 评级。最后，摩根大通将 Heartflow 的目标股价从 36.00 美元上调至 40.00 美元，并在 11 月 13 日的报告中给予该公司 “增持” 评级。四位投资分析师对该股票给予了买入评级，两位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，该股票的平均评级为 “持有”，共识目标价为 38.60 美元。</p>
</div><p><strong>Check Out Our Latest Research Report on HTFL</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 HTFL 的最新研究报告</strong></p>
</div><h2>Heartflow Trading Down 4.0%</h2>
<div class="lb-trans"><h2>Heartflow 股价下跌 4.0%</h2>
</div><p>Shares of NASDAQ:HTFL opened at $32.16 on Friday. The company has a market capitalization of $2.74 billion and a price-to-earnings ratio of -17.77. The stock's fifty day moving average is $30.42. Heartflow, Inc. has a fifty-two week low of $25.38 and a fifty-two week high of $41.22.</p>
<div class="lb-trans"><p>NASDAQ:HTFL 的股票在周五以 32.16 美元开盘。该公司的市值为 27.4 亿美元，市盈率为-17.77。该股票的 50 日移动平均线为 30.42 美元。Heartflow, Inc.的 52 周低点为 25.38 美元，52 周高点为 41.22 美元。</p>
</div><h2>Insider Activity at Heartflow</h2>
<div class="lb-trans"><h2>Heartflow 内部活动</h2>
</div><p>In other news, Director Jeffrey C. Lightcap acquired 40,000 shares of the business's stock in a transaction dated Tuesday, December 16th. The stock was purchased at an average price of $26.34 per share, for a total transaction of $1,053,600.00. Following the completion of the transaction, the director directly owned 40,000 shares in the company, valued at approximately $1,053,600. This trade represents a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through the SEC website.</p>
<div class="lb-trans"><p>在其他新闻中，董事 Jeffrey C. Lightcap 于 12 月 16 日以每股 26.34 美元的平均价格购买了 40,000 股该公司的股票，总交易额为 1,053,600.00 美元。交易完成后，该董事直接持有该公司 40,000 股，价值约为 1,053,600 美元。这笔交易代表了其持股的∞增长。该收购在向证券交易委员会的文件中披露，相关信息可通过 SEC 网站获取。</p>
</div><h2>Heartflow Company Profile</h2>
<div class="lb-trans"><h2>Heartflow 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.</p>
<div class="lb-trans"><p>HeartFlow, Inc. NASDAQ: HTFL 是一家医疗技术公司，开发用于冠状动脉疾病的非侵入性诊断解决方案。该公司的核心产品将冠状动脉 CT 血管造影（CTA）数据转化为患者特定的三维生理模型。通过先进的图像处理和计算建模，HeartFlow 的分析估算冠状动脉树中的分数流量储备（FFR）值，以识别导致缺血的病变，而无需进行侵入性的压力导丝测量。</p>
</div><p>HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.</p>
<div class="lb-trans"><p>HeartFlow 的基于云的服务与临床工作流程集成：临床医生提交冠状动脉 CTA 图像，并收到详细的彩色三维地图和报告，突出显示特定病变的 FFR 值和生理影响。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Heartflow</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>Do not delete, read immediately</li>
<li>The $100 Trillion AI Story No One Is Telling You</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 Heartflow 更好</li>
<li>家族信托如何帮助保护您的财富</li>
<li>请勿删除，立即阅读</li>
<li>没有人告诉你的 100 万亿 AI 故事</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>用这四个简单步骤 “防止” 您的银行账户受到影响</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SFRGTA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=HTFL"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Heartflow Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1,000 美元在 Heartflow 吗？</h2>
</div><p>Before you consider Heartflow, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 Heartflow 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Heartflow wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买...而 Heartflow 并不在名单上。</p>
</div><p>While Heartflow currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Heartflow 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Baillie Gifford & Co. 在 HeartFlow, Inc. $HTFL 中建立了价值 1.0118 亿美元的头寸